Page last updated: 2024-08-21

dronabinol and Triple Negative Breast Neoplasms

dronabinol has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andradas, C; Blasco-Benito, S; Fernández-Ruiz, J; Flores, JM; Gómez-Cañas, M; Goya, P; Jagerovic, N; Morales, P; Sánchez, C	1

Other Studies

1 other study(ies) available for dronabinol and Triple Negative Breast Neoplasms

Article	Year
Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer. Journal of medicinal chemistry, 2015, Mar-12, Volume: 58, Issue:5 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Benzoquinones; Blotting, Western; Breast; Cannabinoids; Cell Proliferation; Cells, Cultured; Female; Humans; Mice; Mice, Nude; Pyrazoles; Real-Time Polymerase Chain Reaction; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2015

Article

Year

Selective, nontoxic CB(2) cannabinoid o-quinone with in vivo activity against triple-negative breast cancer.

Journal of medicinal chemistry, 2015, Mar-12, Volume: 58, Issue:5

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzopyrans; Benzoquinones; Blotting, Western; Breast; Cannabinoids; Cell Proliferation; Cells, Cultured; Female; Humans; Mice; Mice, Nude; Pyrazoles; Real-Time Polymerase Chain Reaction; Receptor, Cannabinoid, CB2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2015